Article
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders
1 Apr 2022
Abstract excerpt
Frontotemporal dementia (FTD) therapy development is hamstrung by a lack of susceptibility, diagnostic, and prognostic biomarkers. Blood neurofilament light (NfL) shows promise as a biomarker, but studies have largely focused only on core FTD syndromes, often grouping patients with different diagnoses. To expedite the clinical translation of NfL, we avail ARTFL LEFFTDS Longitudinal Frontotemporal Lobar...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
